Higa Tomohiro's Form 4 filing
Tenaya Therapeutics, Inc. (TNYA) · filed Aug 18, 2025
- Accession no.
- 0000950170-25-109915
- Filed
- Aug 18, 2025
- Trade date
- Aug 18, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.70K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Higa TomohiroCIK 0002054280 | Officer (SVP, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | Common Stock | SSaleDisposed | −523 | $1.25 | −$653.75 | 97,777 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −717 | $1.25 | −$896.25 | 97,060 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −1,722 | $1.25 | −$2,152.5 | 95,338 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.